Stuart Wong MD

Oncology•Milwaukee, WI

Professor, Medicine, Medical College of Wisconsin

Join to View Full Profile

9200 W Wisconsin AveNeoplastic DiseasesMilwaukee, WI 53226
Phone+1 414-805-6800
Fax+1 414-805-6805

Education & Training

Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 1994 - 1998
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1990 - 1993
Medical College of WisconsinClass of 1990

Certifications & Licensure

WI State Medical License 1992 - 2025
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Apr 01
Terminated
Phase 3
Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2008 Nov 01
Terminated
Phase 2
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16
Completed
Phase 2
A Study in Advanced Solid Tumors Start of enrollment: 2010 Jun 01
Completed
Phase 2
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
ACTIVE_NOT_RECRUITING
PHASE2
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
Completed
Phase 2
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Completed
Phase 2
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22
ACTIVE_NOT_RECRUITING
PHASE2
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Jan 24
ACTIVE_NOT_RECRUITING
PHASE2
Smartphone Pain App for Assessing Oral Mucositis Pain in Patients Start of enrollment: 2018 Feb 13
TERMINATED
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer Start of enrollment: 2021 Aug 24
COMPLETED
EARLY_PHASE1
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma Start of enrollment: 2018 Nov 14
RECRUITING
PHASE2
Inhibition of Oral Tumorigenesis by Antitumor B Start of enrollment: 2022 Apr 22
RECRUITING
EARLY_PHASE1
Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients Start of enrollment: 2021 Jul 08
COMPLETED
PHASE2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Locked Dimerized CXCL12 Exerts Radiosensitizing Effects in Head and Neck Cancer.
Oscar Villarreal Espinosa, Musaddiq Awan, Abdullah A Memon, Anne Frei, Jamie Foeckler
Head & Neck. 2025-05-01
1 citations
Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy.
Ryan Bonate, Musaddiq J Awan, Heather A Himburg, Stuart Wong, Monica Shukla
Physics and Imaging in Radiation Oncology. 2025-01-01
11 citations
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label,...
Loren K Mell, Pedro A Torres-Saavedra, Stuart J Wong, Julie A Kish, Steven S Chang
The Lancet. Oncology. 2024-12-01

Journal Articles

E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced Melanoma
Arun Nagarajan, Mark R Albertini, Stuart Wong, Noel Laudi, Robert M Conry, Clinical Cancer Research

Press Mentions

“Phenomenal” Results with Perioperative Immunotherapy in NSCLCJune 3rd, 2025
Romiplostim Effective in Managing CIT in GI CancersJune 3rd, 2025
Decades-Long Standard of Care in Head and Neck Cancer Set to Change?June 3rd, 2025
Join now to see all